Evidence map›Paper›PMID 40026808›Full record

ArticleInternational journal of general medicine2025

IGF2BP1 Enhances Neprilysin mRNA Stability to Promote Proliferation, Invasion, and Angiogenesis in Placental Trophoblasts.

ChengLing Fan, HongXia Zhou, YuFei Pan, Dan Lu

Abstract read
In one paragraph

Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

ChengLing FanMedical College, Yangzhou University, Yangzhou, Jiangsu, 225009, People's Republic of China.
HongXia ZhouDepartment of Gynaecology and Obstetrics, Baoying Maternal and Child Health Hospital, Yangzhou, Jiangsu, 225800, People's Republic of China.
YuFei PanChina Pharmaceutical University, Nanjing, Jiangsu, 211100, People's Republic of China.
Dan LuMedical College, Yangzhou University, Yangzhou, Jiangsu, 225009, People's Republic of China.ORCID 0009-0006-7226-3717

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Preeclampsia (PE) is a severe gestational disorder characterized by sudden hypertension and proteinuria, with substantial risks to both mother and fetus. This study aims to delineate the role of neprilysin, a metalloprotease known for its role in modulating vasoactive peptides, in the pathophysiology of PE. Methods: We recruited a cohort of 57 participants, comprising 38 patients diagnosed with PE and 19 healthy controls, matched for demographic and clinical characteristics. Neprilysin expression was assessed in serum and placental tissues through quantitative RT-qPCR and Western blot analyses. Functional impacts of neprilysin modulation were explored via siRNA knockdown and overexpression in HTR8/SVneo cells, followed by assessments of oxidative stress, mitochondrial function, apoptosis, and trophoblast invasion using various biochemical assays including CCK-8, DCFH-DA, JC-1 staining, and flow cytometry. Results: Our results demonstrate a marked overexpression of neprilysin in the serum and placental tissues of PE patients compared to healthy controls. Elevated neprilysin levels were positively correlated with increased systolic and diastolic blood pressures. In functional assays, neprilysin knockdown alleviated H Conclusion: These findings establish neprilysin as a critical mediator in the pathogenesis of PE, where its aberrant overexpression is linked to exacerbated hypertensive symptoms and impaired trophoblast function. The interaction between neprilysin and IGF2BP1 provides a potential therapeutic target for mitigating the progression of PE, suggesting avenues for future intervention strategies.

Indexed as

angiogenesisIGF2BP1neprilysinpreeclampsiaproliferationtrophoblast

Identifiers

PMID40026808
PMCPMC11869756

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.